Abstract

Sterol regulatory element-binding proteins (SREBPs) are a family of transcription factors that regulates cholesterol and lipid metabolism. The active forms of these transcription factors are targeted by a number of post-translational modifications, including phosphorylation. Phosphorylation of Thr-426 and Ser-430 in SREBP1a creates a docking site for the ubiquitin ligase Fbw7, resulting in the degradation of the transcription factor. Here, we identify a novel phosphorylation site in SREBP1a, Ser-434, which regulates the Fbw7-dependent degradation of SREBP1. We demonstrate that both SREBP1a and SREBP1c are phosphorylated on this residue (Ser-410 in SREBP1c). Importantly, we demonstrate that the mature form of endogenous SREBP1 is phosphorylated on Ser-434. Glycogen synthase kinase-3 phosphorylates Ser-434, and the phosphorylation of this residue is attenuated in response to insulin signaling. Interestingly, phosphorylation of Ser-434 promotes the glycogen synthase kinase-3-dependent phosphorylation of Thr-426 and Ser-430 and destabilizes SREBP1. Consequently, mutation of Ser-434 blocks the interaction between SREBP1 and Fbw7 and attenuates Fbw7-dependent degradation of SREBP1. Importantly, insulin fails to enhance the levels of mature SREBP1 in cells lacking Fbw7. Thus, the degradation of mature SREBP1 is controlled by cross-talk between multiple phosphorylated residues in its C-terminal domain and the phosphorylation of Ser-434 could function as a molecular switch to control these processes.

Highlights

  • Ltd. and grants from the Swedish Research Council and the Novo Nordisk Foundation

  • Our results demonstrate that the phosphorylation of Ser-434 in SREBP1 is required for the GSK-3-dependent phosphorylation of Thr-426 and Ser-430 in its phosphodegron

  • Kinase assays with recombinant GSK-3␤ and SREBP1a followed by phosphopeptide mapping indicated that the C terminus of mature SREBP1a contained additional residues phosphorylated by GSK-3

Read more

Summary

Introduction

Ltd. and grants from the Swedish Research Council and the Novo Nordisk Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. To determine if phosphorylation of Ser-434 could be involved in regulating the stability of SREBP1, cells were transfected with mature SREBP1a, either wild-type or the phosphorylation-deficient S434A mutant. HepG2 cells were transfected with an SREBP-responsive promoter-reporter gene in the absence or presence of mature SREBP1a, either wild-type, S434A, or S434D.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call